Comparative factors | Group I: combined therapy group | Group II: EBL group | P value | ||
---|---|---|---|---|---|
Mean/count | %/±SD | Mean/count | %/±SD | ||
Treatment sessions | |||||
 Mean number of treatment sessions | 3.25 | ± 1.07 | 1.95 | ± 0.76 | 0.001* |
 Mean number of banding sessions | 1.5 | ± 1.5 | 1.95 | ± 0.76 | 0.034* |
 Mean bands number used | 8.3 | ± 3.53 | 11.35 | ± 5.44 | 0.042* |
 Recurrence of bleeding from GAVE (after 6 months of follow-up) | 3 | 15% | 2 | 10% | 0.676 |
 Cessation of bleeding (after 6 months of follow-up) | 17 | 85% | 18 | 90% |  |
Treatment outcomes | Â | Â | Â | Â | Â |
 Hemoglobin (g/dl) at baseline | 6.86 | ± 1.25 | 7.71 | ± 1.66 | 0.074 |
 Hospitalization at baseline | 1.60 | ± 1.00 | 1.50 | ± 1.05 | 0.641 |
 Blood transfusion at baseline | 3.90 | ± 2.55 | 3.20 | ± 2.24 | 0.360 |
 Hemoglobin (g/dl)(6 months follow-up) | 9.78 | ± 1.68 | 10.04 | ± 1.93 | 0.646 |
 Hospitalization (6 months follow-up) | 0.40 | ± 0.88 | 0.40 | ± 0.82 | 0.794 |
 Bood transfusion (6 months follow-up) | 0.70 | ± 1.98 | 0.95 | ± 1.88 | 0.462 |
 The mean changes in hemoglobin (g/dl) | 2.92 | ± 1.50 | 2.33 | ± 1.74 | 0.258 |
 The mean changes in hospitalization | -1.2 | ± 1.24 | − 1.10 | ± 0.91 | 0.773 |
 The mean changes in transfusion | -3.20 | ± 2.28 | − 2.25 | ± 1.52 | 0.130 |